Selvita S.A. (FRA:787)

Germany flag Germany · Delayed Price · Currency is EUR
11.05
+0.35 (3.27%)
Last updated: Dec 1, 2025, 8:09 AM CET
2.70%
Market Cap207.01M
Revenue (ttm)87.62M
Net Income (ttm)-678.22K
Shares Outn/a
EPS (ttm)-0.04
PE Ration/a
Forward PE53.12
Dividendn/a
Ex-Dividend Daten/a
Volume129
Average Volumen/a
Open11.05
Previous Close10.70
Day's Range11.05 - 11.05
52-Week Range6.18 - 12.26
Betan/a
RSI72.01
Earnings DateNov 20, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Employees 969
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 787
Full Company Profile

Financial Performance

Financial numbers in PLN Financial Statements

News

There is no news available yet.